Paper · 34739697
A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives.
Evans M and 10 others. Adv Ther, 2022. Cited by 220 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives. Papers, record 34739697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34739697
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Kidney Failure, Chronic | Major topic |
| Renal Insufficiency, Chronic | Major topic |
| Aged | |
| Disease Progression | |
| Humans | |
| Renal Dialysis |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22,815,543 | Estimating the financial cost of chronic kidney disease to the NHS in England. | Nephrol Dial Transplant | 2012 | https://conductscience.org/library/papers/22815543 | PubMed |
| 2 | 32,970,396 | Dapagliflozin in Patients with Chronic Kidney Disease. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32970396 | PubMed |
| 3 | 19,423,570 | Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. | Clin J Am Soc Nephrol | 2009 | https://conductscience.org/library/papers/19423570 | PubMed |
| 4 | 23,727,170 | Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. | Lancet | 2013 | https://conductscience.org/library/papers/23727170 | PubMed |
| 5 | 29,904,224 | The global burden of kidney disease and the sustainable development goals. | Bull World Health Organ | 2018 | https://conductscience.org/library/papers/29904224 | PubMed |
| 6 | 18,486,718 | Chronic kidney disease and its complications. | Prim Care | 2008 | https://conductscience.org/library/papers/18486718 | PubMed |
| 7 | 24,832,096 | Association of walking with survival and RRT among patients with CKD stages 3-5. | Clin J Am Soc Nephrol | 2014 | https://conductscience.org/library/papers/24832096 | PubMed |
| 8 | 33,432,542 | Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review. | Adv Ther | 2021 | https://conductscience.org/library/papers/33432542 | PubMed |
| 9 | 17,440,495 | Chronic kidney disease management in the United Kingdom: NEOERICA project results. | Kidney Int | 2007 | https://conductscience.org/library/papers/17440495 | PubMed |
| 10 | 21,200,043 | Classification of chronic kidney disease: a step forward. | Ann Intern Med | 2011 | https://conductscience.org/library/papers/21200043 | PubMed |
1 to 10 of 51
See all 51 referencesCited by180
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 220 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,989,401 | The association between stress hyperglycemia ratio and adverse outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. | Diabetol Metab Syndr | 2026 | https://conductscience.org/library/papers/42989401 | PubMed |
| 42,940,438 | Cross-Cultural Adaptation and Initial Psychometric Evaluation of the Japanese Version of the Chronic Kidney Disease Self-Efficacy Scale (CKDSE-J). | Healthcare (Basel) | 2026 | https://conductscience.org/library/papers/42940438 | PubMed |
| 42,936,507 | Development and validation of predictive models for the hemodialysis adequacy index (Kt/V) using multiple linear regression and machine learning algorithms. | Front Digit Health | 2026 | https://conductscience.org/library/papers/42936507 | PubMed |
| 42,873,799 | Association between the hemoglobin albumin lymphocyte and platelet score and chronic kidney disease: Insights from patient data and animal models. | PLoS One | 2026 | https://conductscience.org/library/papers/42873799 | PubMed |
| 42,855,255 | Effectiveness of an Artificial Intelligence Health Education Accurately Linking System (AI-HEALS) for the intervention of chronic kidney disease: a randomised controlled trial protocol. | BMJ Open | 2026 | https://conductscience.org/library/papers/42855255 | PubMed |
| 42,709,638 | Comparative Efficacy of Interventions for Vascular Calcification and Stiffness in Dialysis Patients: A Systematic Review and Network Meta-Analysis. | Cardiorenal Med | 2026 | https://conductscience.org/library/papers/42709638 | PubMed |
| 42,700,547 | Association of blood urea nitrogen to high-density lipoprotein ratio with all-cause and cardiovascular mortality in individuals with mildly reduced eGFR. | Clinics (Sao Paulo) | 2026 | https://conductscience.org/library/papers/42700547 | PubMed |
| 42,566,582 | Burden of chronic kidney disease and its attributable risk factors in 204 countries and territories, 1990-2021: Results from the Global Burden of Disease study 2021. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42566582 | PubMed |
| 42,540,427 | Hypertension and Chronic Kidney Disease: A Meta-Analysis. | Cureus | 2026 | https://conductscience.org/library/papers/42540427 | PubMed |
| 42,466,120 | Addressing Unmet Needs in the Management of Chronic Kidney Disease. | Int J Gen Med | 2026 | https://conductscience.org/library/papers/42466120 | PubMed |
1 to 10 of 180
See all 180 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| REN | 5,972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
| SLC5A2 | 6,524 | PubTator's text mining | https://conductscience.org/library/genes/6524 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34739697
GET https://conductscience.org/api/papers/v1/34739697/references?page=2